Literature DB >> 22183141

Censored quantile regression for residual lifetimes.

Mi-Ok Kim1, Mai Zhou, Jong-Hyeon Jeong.   

Abstract

We propose a regression method that studies covariate effects on the conditional quantiles of residual lifetimes at a certain followup time point. This can be particularly useful in cancer studies, where more patients survive cancers initially and a patient's residual life expectancy is used to compare the efficacy of secondary or adjuvant therapies. The new method provides a consistent estimator that often exhibits smaller standard error in real and simulated examples, compared to the existing method of Jung et al. (2009). It also provides a simple empirical likelihood inference method that does not require estimating the covariance matrix of the estimator or resampling. We apply the new method to a breast cancer study (NSABP Protocol B-04, Fisher et al. (2002)) and estimate median residual lifetimes at various followup time points, adjusting for important prognostic factors.

Entities:  

Mesh:

Year:  2011        PMID: 22183141     DOI: 10.1007/s10985-011-9212-2

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  5 in total

1.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

Authors:  Bernard Fisher; Jong-Hyeon Jeong; Stewart Anderson; John Bryant; Edwin R Fisher; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

2.  Nonparametric inference on median residual life function.

Authors:  Jong-Hyeon Jeong; Sin-Ho Jung; Joseph P Costantino
Journal:  Biometrics       Date:  2007-05-14       Impact factor: 2.571

3.  A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

Authors:  Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman B Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; Patrick Therasse; Michael J Palmer; Joseph L Pater
Journal:  N Engl J Med       Date:  2003-10-09       Impact factor: 91.245

4.  A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

Authors:  R Charles Coombes; Emma Hall; Lorna J Gibson; Robert Paridaens; Jacek Jassem; Thierry Delozier; Stephen E Jones; Isabel Alvarez; Gianfilippo Bertelli; Olaf Ortmann; Alan S Coates; Emilio Bajetta; David Dodwell; Robert E Coleman; Lesley J Fallowfield; Elizabeth Mickiewicz; Jorn Andersen; Per E Lønning; Giorgio Cocconi; Alan Stewart; Nick Stuart; Claire F Snowdon; Marina Carpentieri; Giorgio Massimini; Judith M Bliss; Cornelius van de Velde
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

5.  Regression on quantile residual life.

Authors:  Sin-Ho Jung; Jong-Hyeon Jeong; Hanna Bandos
Journal:  Biometrics       Date:  2009-12       Impact factor: 2.571

  5 in total
  2 in total

1.  PSEUDO-VALUE APPROACH FOR CONDITIONAL QUANTILE RESIDUAL LIFETIME ANALYSIS FOR CLUSTERED SURVIVAL AND COMPETING RISKS DATA WITH APPLICATIONS TO BONE MARROW TRANSPLANT DATA.

Authors:  Kwang Woo Ahn; Brent R Logan
Journal:  Ann Appl Stat       Date:  2016-07-22       Impact factor: 2.083

2.  Application of Censored Quantile Regression to Determine Overall Survival Related Factors in Breast Cancer.

Authors:  Javad Faradmal; Ghodratollah Roshanaei; Maryam Mafi; Abdolazim Sadighi-Pashaki; Manoochehr Karami
Journal:  J Res Health Sci       Date:  2016
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.